Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

UK pre-market stocks update – New COVID variant sinks European futures

Published 26/11/2021, 07:20
Updated 26/11/2021, 07:21
© Reuters

By Samuel Indyk

Investing.com – At 07:17GMT, FTSE 100 futures are trading lower by 2.3% at 7139.

In FX markets, GBP/USD is trading at 1.3302, EUR/GBP is trading at 0.8446. The US Dollar Index is down 0.15%.

Today’s calendar looks set to remain quiet with US markets closing early due to Thanksgiving. Highlights include Swiss GDP and Eurozone M3 Money Supply.  

Coronavirus

A new COVID variant, B.1.1.529, discovered in Southern Africa has been described as the “most significant” seen yet. The new variant is highly mutated and there are fears it could be resistant to the current vaccinations.

Stocks

Diageo (LON:DGE) - Commencing next tranche of previously announced £4.5 billion capital return programme. Entered into -discretionary agreement with Goldman Sachs (NYSE:GS) International to enable the company to buy back shares with a value of up to £0.55 billion.

JD Wetherspoon (LON:JDW) – Chairman and founder Tim Martin has accused major shareholder Fidelity of breaking the corporate governance code.

Synthomer (LON:SYNTS) - Appointed Essentra CFO Lily Liu as new CFO, succeeding Steve Bennett.

Essentra (LON:ESNT) - To commence a strategic review of the Packaging division. This review will run in parallel with the previously announced strategic review of Filters, which is progressing as planned. Both reviews are likely to conclude in Q2 2022 at the earliest.

ScS Group (LON:SCSS) - Total two-year like-for-like order growth of 0.9% for the 16 weeks ending 20 November 2021. Seen a reduction in store footfall and conversion over the last seven weeks. At 20 November 2021, the Group's order book was £131.9m, £71.5m above the same point two years ago.

Latest comments

Makes you wonder why they want to make this public… if true they can tweak the vaccines for this, and not mutter a word.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.